Kristopher Hanson serves as Executive at PhaseBio Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Kristopher Hanson has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 5, 2026 involved receiving (via award) 31,395 shares valued at $0.
Kristopher Hanson currently holds 31,395 shares of PhaseBio Pharmaceuticals Inc (PHAS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kristopher Hanson has been a net neutral trader of PHAS stock. They have purchased $0 and sold $0 worth of shares.
Kristopher Hanson's most recent insider trade was on Feb 5, 2026, when they sold 31,395 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 27, 2025 | MPLT | $0 | Award | 27,098 | $N/A | Discretionary |
| May 20, 2022 | PHAS | $3.3K | Award | 4,831 | $0.68 | Discretionary |
| Nov 19, 2021 | PHAS | $3.1K | Award | 1,545 | $2.01 | Discretionary |
| May 20, 2021 | PHAS | $3.0K | Award | 1,088 | $2.80 | Discretionary |
| Nov 20, 2020 | PHAS | $3.0K | Award | 999 | $3.00 | Discretionary |